Skip to content

BIOTEMPO

Active Public limited companyfounded 2015active for 10 yearsChaussée d'Ottenbourg 420, 1300 WavreKBO/BCE: BE 0644.497.692

Lifetime

10 annual accounts with figures on one time axis
peak of €20,245 in 2018
€11,095▲ 40.6%
lowest -€94,929 in 2016
€8,529▲ 483%
peak of €9,696 in 2016
€7,723▲ €8,529
€40,531▼ 31.4%
peak of 0.5 FTE in 2018
-not published
Board13 names since 2015all names
7 directors and 6 others
Documentsfilings and deeds
07-08-20267 days late
2025micro format
Gross margin from €7,889 to €11,095Result from €1,462 to €8,529Equity from -€806 to €7,723Debts from €59,053 to €40,531Cash from €806 to €5,670

Key points

from the 2025 annual accounts

Turnover

≈ €82,000 estimated

The accounts state no turnover.

Debts

€40,531 84% of the balance sheet
Suppliers 14%Taxes and wages 14%Other 72%

Filings

10 annual accounts 6 late
AprilJune31 JulyOctober20202025

The 2019 accounts came in latest, 42 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,052 companies had the same profile as BIOTEMPO has now. Each dot stands for 13 companies, two years later.

95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,052 companies, not a prediction for BIOTEMPO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director
Director
Director
Director
Director
and 1 other
  • 150 sharesdeed of 12-01-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0644497692
6 directors appointed, 2 resignations, 2 reappointments and resign · , , , , and (managing director) appointed · and reappointed · Gazette deed
Registered office moved from Uccle to Wavre The registered office moved from Rue Egide Van Ophem 40C, 1180 UCCLE to 420, chaussée d'Ottenbourg à 1300 Wavre · acts as permanent representative · appointed as director · General meeting of 16-02-2019 · Gazette deed
Registered office moved to Uccle The registered office moved to avenue Egide Van Ophem 40C à 1180 Uccle · acts as permanent representative · resigns as director · General meeting of 03-04-2018 · Gazette deed
All 19 events

Comparable companies

same main activity, similar in size and age
Company
BIOTEMPO Wavre €48,255 €11,095 16.0% -
TEVERINA Borsbeek €37,833 €6,540 41.5% -
1001 CréaCtivités Koekelberg €68,626 €10,416 91.0% -
Betaset Leuven €27,647 €9,716 99.2% -
pour écrire la liberté Ixelles €55,529 €42,389 -35.2% 0
GL HF Jodoigne €25,544 €7,933 -0.3% -
NIZELLES Braine-l'Alleud €46,475 €11,540 67.2% -

These companies have the same main activity as BIOTEMPO: publishing activities (NACE 58130). They are comparable in size and age: total assets between €25,500 and €68,600, founded between 2005 and 2021.

Official details

Source: KBO
Status
Active since 14-12-2015Normal situation
Activity
Publishing activitiesNACE 58130
Establishment unit
2.248.207.6021300 Wavre, registered on 14-12-2015
Financial year end
31 December
Peppol
Reachable since 19-01-2026
Company details

Annual accounts 2025

€48,255▼ 17.2%
Filing
Filed on 07-08-2026
Financials

Insights on BIOTEMPO

BIOTEMPO files the micro format. That format states no turnover. The gross margin rose from -€87,067 in 2016 to €11,095 in 2025.

In August 2023, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOTEMPO

What is the company number of BIOTEMPO?
The company number of BIOTEMPO is 0644.497.692. The VAT number is the same number with BE in front: BE 0644.497.692.
Where is BIOTEMPO based?
The registered office is at Chaussée d'Ottenbourg 420, 1300 Wavre.Company details
What does BIOTEMPO do?
According to the KBO register, the main activity is publishing activities (NACE 58130).
What is the legal form of BIOTEMPO?
BIOTEMPO is a public limited company (NV).
When was BIOTEMPO founded?
BIOTEMPO was founded on 14-12-2015.
Is BIOTEMPO still active?
Yes, BIOTEMPO is an active enterprise in the KBO register.
How many employees does BIOTEMPO have?
BIOTEMPO had an average of 0.5 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of BIOTEMPO?
The turnover in financial year 2025 is about €82,000. This figure is estimated from the gross margin of €11,095 and 7,100 comparable companies of the same size. It probably lies between €37,000 and €200,000. It is a rough estimate. In financial year 2021 turnover was €306,990.
Is BIOTEMPO profitable?
In financial year 2025, BIOTEMPO made a profit of €8,529.
Where can I find the annual accounts of BIOTEMPO?
BIOTEMPO filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOTEMPO due?
BIOTEMPO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.